secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001193125-23-267486
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRIDEX withdraws FY2023 guidance after Medicare LCD restricts glaucoma reimbursement
--------------------------------------------------------------------------------

- WPS Medicare LCD effective Dec 24, 2023 will likely limit cyclophotocoagulation coverage to only refractory glaucoma patients meeting strict criteria.
- Company withdrawing previously announced 2023 annual guidance due to uncertainty from the LCD.
- WPS jurisdiction covers ~8% of US glaucoma probe sales; similar MAC actions could impact majority of US glaucoma revenue.
- IRIDEX plans to appeal LCD, engage with MACs, and initiate a clinical study to meet LCD evidence requirements.
- Outside US (50% of glaucoma revenue) not materially impacted by the LCD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000119312523267486/0001193125-23-267486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000119312523267486/d533658d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-267486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer